Synthesis, Biological Activity, and Docking Studies of New Acetylcholinesterase Inhibitors of the Bispyridinium Type

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archiv der Pharmazie

• Publication date

  2003-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/ardp.200300795PMID 14639745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cation-pi interactions in ligand recognition and catalysis.

  2002cited by this paper
• Molecular dynamics of acetylcholinesterase.

  2002cited by this paper
• Homodimeric tacrine congeners as acetylcholinesterase inhibitors.

  2002cited by this paper
• 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.

  2002cited by this paper
• Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.

  2001cited by this paper
• Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors

  2001cited by this paper
• Dynamic Deconvolution of a Pre‐Equilibrated Dynamic Combinatorial Library of Acetylcholinesterase Inhibitors

  2001cited by this paper
• Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts.

  2000cited by this paper
• Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors.

  1999cited by this paper
• Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution

  1999cited by this paper
• A modular treatment of molecular traffic through the active site of cholinesterase.

  1999cited by this paper
• Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.

  1999cited by this paper
• Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis.

  1999cited by this paper
• Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

  1998cited by this paper
• Structure-based drug design.

  1998cited by this paper
• Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.

  1998cited by this paper
• Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.

  1998cited by this paper
• Stability of mono- and bisbenzyloxime ethers of the acetylcholinesterase reactivator TMB-4.

  1997cited by this paper
• Conformational Analysis, Molecular Shape Comparison, and Pharmacophore Identification of Different Allosteric Modulators of Muscarinic Receptors

  1996cited by this paper
• A fast flexible docking method using an incremental construction algorithm.

  1996cited by this paper
• Variation of the oxime function of bispyridinium-type allosteric modulators of M2-cholinoceptors.

  1995cited by this paper
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

  1994cited by this paper
• Three-dimensional structures of acetylcholinesterase and of its complexes with anticholinesterase agents.

  1994cited by this paper
• Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.

  1994cited by this paper
• Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.

  1994cited by this paper
• Quaternary salts of 3,3'-bis-pyridinium monooximes: synthesis and biological activity.

  1993cited by this paper
• Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.

  1993cited by this paper
• Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.

  1992cited by this paper
• MOPAC: A semiempirical molecular orbital program

  1990cited by this paper
• Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

  1988cited by this paper
• Interdependence between physical parameters and selection of substituent groups for correlation studies.

  1971cited by this paper
• [Behavior of N-alkyl-pyridinium-aldoximes in water-alkaline solution].

  1968cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Exploring Pyridinium-Based Inhibitors of Cholinesterases: A Review of Synthesis, Efficacy, and Structural Insights

  2025cites this paper
• The synthesis and influence of the novel bispyridinium compound LB1 on the effectiveness of the standard antidotal treatment of organophosphorus nerve agent intoxicated mice and some structure-activity considerations.

  2025cites this paper
• Ampere-Level Electrosynthesis of 15N-Labeled Oximes by Alloy Synergy Activation and Hydroxylamine Overhydrogenation Inhibition.

  2025cites this paper
• 3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide Derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model

  2024cites this paper
• Design, Creation, and Biological Screening of Newer Coumarin-Coupled Heterocyclic Hybrids as Acetylcholinesterase Inhibitors that may be Useful in the Treatment of Alzheimer’s Disease

  2024cites this paper
• Metal-Free Transformation of Sulfonyl Oxime Ethers with Amines to Oxime Ethers.

  2021cites this paper
• Synthesis and cholinesterase inhibitory activity studies of some piperidinone derivatives

  2019cites this paper
• Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.

  2019cites this paper
• Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach.

  2019cites this paper
• Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

  2018cites this paper
• Synthesis, biological evaluation, and docking studies of some 5‐chloro‐2(3H)‐benzoxazolone Mannich bases derivatives as cholinesterase inhibitors

  2018cites this paper
• Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.

  2017cites this paper
• Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors

  2016cites this paper
• Hybrids: a new paradigm to treat Alzheimer’s disease

  2016cites this paper
• Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.

  2016cites this paper
• 1H-benzimidazole derivatives as butyrylcholinesterase inhibitors: synthesis and molecular modeling studies

  2016cites this paper
• Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1 H-pyrazole or 1 H-1 , 2 , 4-triazole

  2016cites this paper
• Investigation on the Binding Affinities of Different Anthelmintic Drugs on the 3D Model Protein Structure of Acetylcholinesterase of Schistosoma mansoni: An in silico Approach

  2015cites this paper
• A Green Method for Synthesis of 7H-thiazolo[3,2-b][1,2, 4]-triazin-7-one Derivatives as AChE Inhibitors

  2015cites this paper
• Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.

  2014cites this paper
• 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.

  2013cites this paper
• Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.

  2013cites this paper
• Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells

  2013cites this paper
• Design, Synthesis, and Biological Evaluation of 7H-Thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives as Dual Binding Site Acetylcholinesterase Inhibitors

  2013cites this paper
• Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.

  2013cites this paper
• Synthesis and acetylcholinesterase (AChE) inhibitory activity of some N-substituted-5-chloro-2(3H)- benzoxazolone derivatives

  2013cites this paper
• Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.

  2013cites this paper
• 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets.

  2012cites this paper
• The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.

  2012cites this paper
• Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits

  2012cites this paper
• Preparation of N-phenylbenzo[h]quinolinium derivatives labeled with tritium

  2012cites this paper
• Multi-target-directed ligands in Alzheimer's disease treatment.

  2011cites this paper
• In silico methods to assist drug developers in acetylcholinesterase inhibitor design.

  2011cites this paper
• Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.

  2010cites this paper
• Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction.

  2010cites this paper
• Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives.

  2010cites this paper
• Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.

  2010cites this paper
• New Bisquaternary Isoquinolinium Inhibitors of Brain Cholinesterases - Synthesis and Anticholinesterase Activity

  2010cites this paper
• Multivalent & multifunctional ligands to beta-amyloid.

  2009cites this paper
• SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF SOME PYRIDINIUM

  2008cites this paper
• From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease.

  2008cites this paper
• Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.

  2008cites this paper
• Interaction of Bispyridinium Compounds with Phospholipid Layers in Presence and Absence of Electric Field

  2007cites this paper
• Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.

  2007cites this paper
• Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

  2007cites this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cites this paper
• Muscarinic Allosteric Modulators: Atypical Structure‐Activity‐Relationships in Bispyridinium‐type Compounds

  2006cites this paper
• Random Chemistry as a New Tool for the Generation of Small‐Compound Libraries

  2006cites this paper
• Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes

  2006cites this paper
• Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity.

  2006cites this paper
• Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.

  2005cites this paper
• Random chemistry as a new tool for the generation of small compound libraries: development of a new acetylcholinesterase inhibitor.

  2005cites this paper
• Structure-Based Validation of the 3D-QSAR Technique MaP

  2005cites this paper
• Synthesis and biological activity of pyridinium‐type acetylcholinesterase inhibitors

  2003cites this paper